European Pharmaceutical Market Access, Pricing and Reimbursement

SMi Group’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference returns to London from 10-11 October 2016. The conference is one of the most established in the world, focusing on the changes in pricing and reimbursement and market access. This year’s agenda will have a strong focus on the future of pricing and reimbursement. Other key topics include:Updates on AMNOG and its implication on pricing and reimbursement;How biosimilars are affecting your pricing strategy;Capture on emerging markets’ regulatory framework to adapt your market access and P&R models;Orphan drugs using recent examples to highlight the impact on pricing;Cancer drug funding and budget cuts in the UK;Innovative solutions beyond the pill;Japanese and Turkish regional updates. To register: contact Fateja Begum on +44 (0)20 7827 6184 or email: fbegum@smi-online.co.uk

Bitnami